These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34261348)

  • 1. Adolescents' Experiences of Using a Smartphone Application Hosting a Closed-loop Algorithm to Manage Type 1 Diabetes in Everyday Life: Qualitative Study.
    Rankin D; Kimbell B; Allen JM; Besser REJ; Boughton CK; Campbell F; Elleri D; Fuchs J; Ghatak A; Randell T; Thankamony A; Trevelyan N; Wilinska ME; Hovorka R; Lawton J
    J Diabetes Sci Technol; 2021 Sep; 15(5):1042-1051. PubMed ID: 34261348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial.
    Ware J; Boughton CK; Allen JM; Wilinska ME; Tauschmann M; Denvir L; Thankamony A; Campbell FM; Wadwa RP; Buckingham BA; Davis N; DiMeglio LA; Mauras N; Besser REJ; Ghatak A; Weinzimer SA; Hood KK; Fox DS; Kanapka L; Kollman C; Sibayan J; Beck RW; Hovorka R;
    Lancet Digit Health; 2022 Apr; 4(4):e245-e255. PubMed ID: 35272971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescents' and their parents' experiences of using a closed-loop system to manage type 1 diabetes in everyday life: qualitative study.
    Rankin D; Kimbell B; Hovorka R; Lawton J
    Chronic Illn; 2022 Dec; 18(4):742-756. PubMed ID: 33472409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parents' experiences of using a hybrid closed-loop system (CamAPS FX) to care for a very young child with type 1 diabetes: Qualitative study.
    Kimbell B; Rankin D; Hart RI; Allen JM; Boughton CK; Campbell F; Fröhlich-Reiterer E; Hofer SE; Kapellen TM; Rami-Merhar B; Schierloh U; Thankamony A; Ware J; Hovorka R; Lawton J;
    Diabetes Res Clin Pract; 2022 May; 187():109877. PubMed ID: 35469973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Impact of Applying Personal Glucose Targets in a Closed-Loop System for People With Type 1 Diabetes.
    Fattah M; Boughton CK; Ware J; Allen JM; Hartnell S; Willinska ME; Thankamony A; de Beaufort C; Campbell FM; Fröhlich-Reiterer E; Hofer SE; Kapellen TM; Rami-Merhar B; Ghatak A; Randell TL; Besser REJ; Elleri D; Trevelyan N; Denvir Md L; Davis N; Bally L; Thabit H; Leelarathna L; Evans ML; Mader JK; Hovorka R
    J Diabetes Sci Technol; 2024 May; 18(3):695-700. PubMed ID: 36540007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.
    Lawton J; Blackburn M; Rankin D; Allen JM; Campbell FM; Leelarathna L; Tauschmann M; Thabit H; Wilinska ME; Elleri D; Hovorka R
    Diabetes Technol Ther; 2019 Mar; 21(3):119-127. PubMed ID: 30720338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world lived experience of older adults with type 1 diabetes after an automated insulin delivery trial.
    Kubilay E; Trawley S; Ward GM; Fourlanos S; Colman PG; McAuley SA
    Diabet Med; 2024 Apr; 41(4):e15264. PubMed ID: 38073128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lived Experience of Fully Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Lakshman R; Hartnell S; Ware J; Allen JM; Wilinska ME; Nwokolo M; Evans ML; Hovorka R; Boughton CK
    Diabetes Technol Ther; 2024 Apr; 26(4):211-221. PubMed ID: 38426909
    [No Abstract]   [Full Text] [Related]  

  • 11. Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents.
    Hood KK; Garcia-Willingham N; Hanes S; Tanenbaum ML; Ware J; Boughton CK; Allen JM; Wilinska ME; Tauschmann M; Denvir L; Thankamony A; Campbell F; Wadwa RP; Buckingham BA; Davis N; DiMeglio LA; Mauras N; Besser REJ; Ghatak A; Weinzimer SA; Fox DS; Kanapka L; Kollman C; Sibayan J; Beck RW; Hovorka R;
    Diabetes Obes Metab; 2022 Dec; 24(12):2309-2318. PubMed ID: 35837984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rollout of Closed-Loop Technology to Pregnant Women with Type 1 Diabetes: Healthcare Professionals' Views About Potential Challenges and Solutions.
    Rankin D; Hart RI; Kimbell B; Barnard-Kelly K; Brackenridge A; Byrne C; Collett C; Dover AR; Hartnell S; Hunt KF; Lee TTM; Lindsay RS; McCance DR; McKelvey A; Rayman G; Reynolds RM; Scott EM; White SL; Hovorka R; Murphy HR; Lawton J
    Diabetes Technol Ther; 2023 Apr; 25(4):260-269. PubMed ID: 36662589
    [No Abstract]   [Full Text] [Related]  

  • 13. Hybrid closed-loop therapy: Where are we in 2021?
    Leelarathna L; Choudhary P; Wilmot EG; Lumb A; Street T; Kar P; Ng SM
    Diabetes Obes Metab; 2021 Mar; 23(3):655-660. PubMed ID: 33269551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lived experience of older adults with type 1 diabetes using closed-loop automated insulin delivery in a randomised trial.
    Kubilay E; Trawley S; Ward GM; Fourlanos S; Grills CA; Lee MH; MacIsaac RJ; O'Neal DN; O'Regan NA; Sundararajan V; Vogrin S; Colman PG; McAuley SA
    Diabet Med; 2023 Apr; 40(4):e15020. PubMed ID: 36468784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System.
    Suttiratana SC; Wong JJ; Lanning MS; Dunlap A; Hanes SJ; Hood KK; Lal RA; Naranjo D
    Diabetes Technol Ther; 2022 Jun; 24(6):416-423. PubMed ID: 35099278
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.
    Beato-Víbora PI; Gallego-Gamero F; Lázaro-Martín L; Romero-Pérez MDM; Arroyo-Díez FJ
    Diabetes Technol Ther; 2020 Dec; 22(12):912-919. PubMed ID: 31855446
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.
    Thabit H; Boughton C; Mubita W; Rubio J; Mader JK; Narendran P; Evans M; Leelarathna L; Wilinska ME; Fullwood C; Gregory AM; Hovorka R; Rutter MK
    Diabetes Obes Metab; 2023 Mar; 25(3):889-893. PubMed ID: 36335565
    [No Abstract]   [Full Text] [Related]  

  • 20. "It Is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes.
    Hendrieckx C; Poole LA; Sharifi A; Jayawardene D; Loh MM; Horsburgh JC; Bach LA; Colman PG; Kumareswaran K; Jenkins AJ; MacIsaac RJ; Ward GM; Grosman B; Roy A; O'Neal DN; Speight J
    Diabetes Technol Ther; 2017 Jul; 19(7):410-416. PubMed ID: 28537437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.